Juliane Manitz - Concepedia

Author

Juliane Manitz

University of Göttingen ORCID

Also Known As

Eric Milliman, J. Manitz, Juliane Manitz, Manitz, J., Manitz, Juliane

Publications

637

Citations

H-Index

Concepts

All Affiliations

University of Göttingen Merck (Germany)National Cancer Institute Ono Pharmaceutical (United States)National Institutes of Health

About

Juliane Manitz is an author at University of Göttingen specializing in medicine, public health, and disease propagation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	191
2	Public Health	3	3	78
3	Biostatistics	2	2	47
4	Engineering	1	1	16
5	Health Sciences	1	1	29

Juliane Manitz

Publications

573

Citations

H-Index

Page 1

	Year	Citations
Two different sides of ‘chemobrain’: determinants and nondeterminants of self‐perceived cognitive dysfunction in a prospective, randomized, multicenter study Kerstin Hermelink, Helmut Küchenhoff, Michael Untch, Psycho-Oncology	2010	131
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis Andrea B. Apolo, John Ellerton, Jeffrey R. Infante, Journal for ImmunoTherapy of Cancer	2020	81
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors Guru Sonpavde, Juliane Manitz, Chen Gao, The Journal of Urology	2020	73
Prevalence of Anaplasma phagocytophilum in Ixodes ricinus in Bavarian public parks, Germany Sabine Schorn, Kurt Pfister, H.-J. Reulen, Ticks and Tick-borne Diseases Parasitic DiseaseIxodes RicinusZoonotic DiseaseAnaplasma PhagocytophilumSoil-transmitted Helminthiasis	2011	60
Origin Detection During Food-borne Disease Outbreaks - A Case Study of the 2011 EHEC/HUS Outbreak in Germany Juliane Manitz, Thomas Kneib, Martin Schlather, PLoS Currents Disease MappingEpidemiological DynamicNetwork AnalysisDisease OutbreakComputational Epidemiology	2014	37
Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival Juliane Manitz, Sandra P. D’Angelo, Andrea B. Apolo, Journal for ImmunoTherapy of Cancer	2022	33
A Network-Based Kernel Machine Test for the Identification of Risk Pathways in Genome-Wide Association Studies Saskia Freytag, Juliane Manitz, Martin Schlather, Human Heredity GeneticsGenetic EpidemiologyGenomicsGenome-wide Association StudiesGenome-wide Association Study	2013	31
Estimands for overall survival in clinical trials with treatment switching in oncology Juliane Manitz, Natalia Kan‐Dobrosky, Hannes Buchner, Pharmaceutical Statistics Preclinical TherapeuticsPatient SelectionCancer ManagementClinical EndpointTreatment Plan Evaluation	2021	29
Efficacy and immune-related adverse event associations in avelumab-treated patients Karen Kelly, Juliane Manitz, Manish R. Patel, Journal for ImmunoTherapy of Cancer	2020	26
Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab Nadia Terranova, Jonathan French, Haiqing Dai, CPT Pharmacometrics & Systems Pharmacology Gastrointestinal PharmacologyCancer ManagementPrognosisGastroenterologyPathology	2021	24

Page 1